# Monica Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/monica-healthcare

- Industry: Medical Devices & Equipment
- Headquarters: Nottingham, UK
- Website: www.monicahealthcare.com
- Total disclosed funding: $1.3M
- Latest round: Series B (Jul 2, 2007)
- Investors on record: 2

## About

Monica Healthcare Ltd is a healthcare technology company specializing in innovative solutions to enhance maternal and fetal health through advanced monitoring technologies.Founded in 2005 in Nottingham, UK, Monica Healthcare Ltd focuses on developing healthcare solutions for maternal and fetal monitoring. The company was acquired by GE Healthcare in March 2017, with the financial terms of the transaction remaining undisclosed. Throughout its history, Monica Healthcare has completed 10 deals, raising a total of GBP 0.940 mn, with a current valuation of GBP 10.494 mn.Monica Healthcare specializes in innovative healthcare solutions designed to improve patient monitoring and care. Their primary product offerings focus on advanced monitoring technologies that allow for real-time data collection and analysis, significantly enhancing the management of maternal and fetal health. The company's target client base includes healthcare providers, hospitals, and clinics, particularly in the United States, Canada, and select European markets where maternal health care is a priority.Monica Healthcare generates revenue through a structured model that includes direct sales of its flagship monitoring systems to healthcare institutions. For the most recent year, 2019, the company reported a revenue of GBP 0 mn and an EBITDA of GBP 107,607.5 for 2022. The company employs a B2B transaction framework, where healthcare providers purchase equipment and software subscriptions that facilitate ongoing patient monitoring services.Monica Healthcare's growth strategy includes launching new products aimed at enhancing maternal and fetal health monitoring capabilities in the coming years. The company plans to expand into new geographic markets, particularly emphasizing growth in the United States and select European regions by 2025. The funding raised prior to its acquisition will support these initiatives, enabling the company to continue developing innovative monitoring solutions.

## Funding rounds

- Series B, Jul 2, 2007, $1.3M — Catapult Ventures Group, The Lachesis Fund

## Investors

- Catapult Ventures Group (https://capitalatlas.ai/funds/catapult-ventures-group) — Series B
- The Lachesis Fund (https://capitalatlas.ai/funds/the-lachesis-fund) — Series B